This paper argues that length and weight are not interchangeable controls. Length measures one geometric dimension. Weight measures the total quantity of finished material present in the unit. For products intended to deliver a defined amount of formulated material and active substance per implant, weight is usually the more relevant primary physical indicator of dose integrity, while length is better treated as a supporting dimensional attribute unless a manufacturer has demonstrated that length is a reliable surrogate within a tightly controlled process.
This conclusion is consistent with modern pharmaceutical development principles, which require control strategies to be based on critical quality attributes, process understanding, and scientific justification. It is also directionally aligned with pharmacopoeial treatment of implants, which includes them within uniformity of mass of single-dose preparations.
Key Points
- Length and weight do not measure the same thing.
- Length confirms geometry.
- Weight confirms the quantity of finished material present.
- For medicated implants, dose integrity is more closely linked to mass than to length alone.
- Length may still have value as a supporting or surrogate measure, but only where that relationship has been demonstrated.
- A robust control strategy should be based on scientific relevance, not measurement convenience alone
Download the CiP White Paper: Length vs weight in medicated implant quality control by Phillip Ruda here.
